COMPANY PROFILE

Onego Bio

Explore full profile

Real egg protein, no shells attached

Helsinki, FinlandFounded 2022Food

Valuation $100–250M Last recorded · 2024

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Onego Bio

Onego Bio is a food ingredient company on a mission to create a more resilient food system through its product Bioalbumen®—the first non-animal egg protein with an amino acid sequence identical to the natural protein. Made through precision fermentation, Bioalbumen® matches the nutrition and functionality of traditional eggs while delivering greater supply stability, consistent pricing, and 90% lower environmental impact.

Read full description

With a proven industrial-scale process, FDA GRAS status, and technological development that advances positive unit economics, Onego Bio is addressing the $300BN egg market by helping food manufacturers meet rising demand for reliable protein without compromising on performance. From baked goods to sauces and ready-to-eat meals, Bioalbumen® fits seamlessly into existing formulations—making the transition to smarter proteins easier than ever.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2022
Headquarters: Helsinki, Finland
Employees: 61
Open positions: None listed
Dealroom signal: 81.3/100
Sub-industry: Innovative Food
Sector: Food, Biotechnology, Synthetic Biology, Spinout, Alternative Protein, Sustainable Development Goals, Egg Substitute, EIC, Fermentation, Climate Tech
Technology: Hardware, Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GRANTOther financing	Sep 2024	$2M	—	US Department of War	↗
EARLY VCOther financing	Sep 2024	$0	—	Newtree Impact	↗

Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Onego Bio website traffic

Latest recorded traffic for Onego Bio is 5.3K monthly website visits, up 0% over the last three months. Onego Bio's team grew 3.4% over the past year.

Latest monthly visits5.3K 3-month web change0% 1-year team growth+3.4%

Monthly website visitsNov 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
MEMelt&MarbleDevelops precision-fermented, animal-free fats that replicate the structure and taste of animal fats for plant-based and alternative meat products	Göteborgs Stad, Sweden	Operational	24	$17M	$32M
BIBIOWEGBio-based ingredient alternatives to petroleum-based chemicals	Quakenbrück, Germany	Operational
ÄIÄIOUsing innovative technology to produce healthy fats and oils for a healthier diet	Tallinn, Estonia	Operational
MYMyco4FoodDeveloping a scalable bioreactor system for solid-state fermentation	Copenhagen, Denmark	Operational
MIMicroHarvestSustainable protein ingredients from microbial biomass fermentation.	Hamburg, Germany	Operational
MYMycorenaMaking sustainable fungi-based vegan protein, while reducing waste and water usage in food industry	Göteborgs Stad, Sweden	Acquired
IRInfinite RootsUsing biotechnology to create the next generation of sustainable foods from the roots of mushrooms	Hamburg, Germany	Operational
MFMoa FoodtechMakes healthy food for a sustainable world that solves growing global food demands	Noáin (Valle de Elorz)/Noain (Elortzibar), Spain	Operational